Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 20 Aug 2026 for Regeneron Pharmaceuticals, INC., €2.1M. Read the official filing
Filing timeline
BuySaleChristopher R. Fenimore
Insider track record
Disclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher R. Fenimore: trading record in brief
All filings by Christopher R. Fenimore on record concern Regeneron Pharmaceuticals, Inc., in the capacity of finance chief. The record holds 26 filings, for trades running from 20 August 2021 to 18 August 2026.
Every open-market trade on record is a sale: 7 sales worth €8.3M. Besides market trades, the filings include 11 share grants and 8 option exercises.
Most recently, on 20 August 2026, the filings show an option exercise worth €2.1M in Regeneron Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Christopher R. Fenimore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
6,283 shares@ US$381.920.0028% mcap5.9% of flowCommon StockSEC:0001697422-26-000002:0
4,599 shares@ US$813.470.0044% mcap9.3% of flowCommon StockSEC:0001697422-26-000002:1
3,027 shares0Common StockSEC:0001697422-25-000004:0
491 shares@ US$730.810.9% of flowCommon StockSEC:0001883850-24-000061:0
2,591 shares0Common StockSEC:0001883850-24-000050:0
228 shares@ US$1,204.790.7% of flowCommon StockSEC:0001883850-24-000045:0
344 shares@ US$950.490.8% of flowCommon StockSEC:0001968202-24-000061:0
5,000 shares@ US$555.676.9% of flowCommon StockSEC:0001968202-24-000041:0
5,000 shares@ US$555.676.9% of flowCommon StockSEC:0001883850-24-000008:0
2,448 shares@ US$856.715.2% of flowCommon StockSEC:0001883850-23-000107:0
456 shares@ US$843.791.0% of flowCommon StockSEC:0001883850-23-000103:0
2,552 shares@ US$856.715.5% of flowCommon StockSEC:0001883850-23-000101:0
474 shares@ US$843.791.0% of flowCommon StockSEC:0001968202-23-000050:0
7,000 shares@ US$399.667.0% of flowCommon StockSEC:0001968202-23-000031:0
2,192 shares@ US$806.474.4% of flowCommon StockSEC:0001883850-23-000060:0
5,000 shares@ US$270.433.4% of flowCommon StockSEC:0001883850-23-000037:0
1,926 shares0Common StockSEC:0001883850-22-000131:0
247 shares@ US$753.280.5% of flowCommon StockSEC:0001883850-22-000117:0
1,844 shares@ US$749.003.8% of flowCommon StockSEC:0001883850-22-000080:0
3,346 shares@ US$724.006.7% of flowCommon StockSEC:0001883850-22-000077:0
2,450 shares@ US$555.674.2% of flowCommon StockSEC:0001708138-22-000039:0
2,000 shares@ US$555.673.4% of flowCommon StockSEC:0001883850-22-000029:0
270 shares@ US$664.340.5% of flowCommon StockSEC:0001708138-21-000106:0
1,859 shares0Common StockSEC:0001883850-21-000022:0
8,719 shares@ US$664.8516.8% of flowCommon StockSEC:0001104659-21-109328:0
25 of 26 declarations
